… study, we aimed to develop a therapy against erlotinib resistance. We observed that HDAC6
is overexpressed in erlotinib… is responsible for erlotinib resistance in pancreatic cancer cells. …

… Aims: The purpose of this study was to evaluate how erlotinib and garcinia cambogia alleviate
the harmful effects of adenine on the rat’s kidneys. Methods: Forty animals were divided …

… Aim: This study aimed to formulate erlotinib hydrochloride (ERT-HCL)-loaded chitosan (CS)
and poly (lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) using Quality-by-Design (QbD) …

… To address this gap, we conducted a comparative study of matched biopsies and surgical
… Our study reveals a lack of correlation between PD-L1 and MET expression in NSCLC …

… Erlotinib was connected to MoS 2 via click chemistry with PEG as a linker. … The results
of this study demonstrate the excellent antitumor effect of MoS 2 -PEG-Er/DOX, providing a …

… this study is to elucidate whether Hsp90 inhibitor 17-AAG could enhance tamoxifen- and
erlotinib-… and cell growth inhibitory effects of tamoxifen and erlotinib in NSCLC cells, which were …

… of erlotinib vs no initiation of erlotinib in individuals receiving gemcitabine. All components
of the treatment strategy needed to be in place within a prespecified period (the grace period) …

Purpose: The present study aims to describe the differences in the prevalence of EGFR
mutation of lung adenocarcinoma between private and public healthcare institutions. Methods: …

… success, we synthesized a series of novel erlotinib–chalcone molecular hybrids with 1,2,3-…
compared to the 1:1 combination of erlotinib and a reference chalcone. The clonogenic …

… CONSORT diagram and study design. The selection criteria for PDX used in this study are
… The selection criteria for PDX used in this study are shown in A. Of the 55 lung cancer PDXs…